Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 968 12.24 (1.28%) Market Cap: 106.66 Bil Enterprise Value: 97.49 Bil PE Ratio: 28.60 PB Ratio: 3.95 GF Score: 94/100

Q1 2019 Regeneron Pharmaceuticals Inc Earnings Call Transcript

May 07, 2019 / 12:30PM GMT
Release Date Price: $322.4 (-6.34%)
Operator

Good morning and welcome to the Regeneron Pharmaceuticals First Quarter 2019 Earnings Conference Call. My name is Brandon, and I'll be your operator for today. (Operator Instructions) Please note this conference is being recorded.

And I will now turn it over to Mark Hudson. You may begin, sir.

Mark Hudson
Regeneron Pharmaceuticals, Inc. - IR Executive

Thank you, Brandon. Good morning, and welcome to Regeneron Pharmaceuticals First Quarter 2019 Conference Call. An archive of this webcast will be available on our website for 30 days under Events.

Joining me on the call today are Dr. Leonard Schleifer, Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Founding Scientist, President and Chief Scientific Officer; Marion McCourt, Senior Vice President and Head of Commercial; and Bob Landry, Executive Vice President and Chief Financial Officer. After our prepared remarks, we'll open up the call for Q&A.

I'd also like to remind you that remarks made on this call today include forward-looking statements about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot